← Leaderboards
Rieko Ishima
University Of Pittsburgh At Pittsburgh
$4,470,162
Attributed
$5,060,464
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $587.9K · FY2009–25$1M$750K$500K$250K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,060,464 · 7
By mechanism
P50$2,331,024 · 3
R01$2,145,462 · 2
R21$432,058 · 1
R03$151,920 · 1
Top collaborators
- Wei Li2 shared
- Michael A Parniak2 shared
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Nicolas P Sluis-Cremer$13,171,852
- Peter X Wipf$9,740,940
- John W Mellors$70,850,753
- Alexander Deiters$7,387,118
- Gerard L Apodaca$21,037,813
Others in their field
Top investigators on “Structure”
- David Heimbrook · Leidos Biomedical Research, Inc.$475,333,582
- Barton F Haynes · Duke University$444,977,767
- Lawrence Corey · Fred Hutchinson Cancer Center$334,646,086
- Gary D Acton · University Of California-Davis$320,373,312
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
- Michael David Hughes · Harvard University D/B/A Harvard School Of Public Health$315,257,203
Research focus
StructureSiteMolecular ConformationRibonuclease HRna-Directed Dna PolymeraseBaseLabelInsightProteinsDbl OncoproteinBinding SitesComplexBiochemicalInhibitor/AntagonistPolymeraseEnzymesHiv-1Signal TransductionResearch StudySamplingC-TerminalCellsMutantBinding (Molecular Function)
Grant awards (22)
Development of a biparatopic-domain antibody screening system$198,160
R21 · FY2025 · ES · contact PI
NMR strategies to probe allosteric effects of inhibitor binding on AML-associated Src-family kinases$151,920
R03 · FY2025 · CA · contact PI
Development of a biparatopic-domain antibody screening system$233,898
R21 · FY2024 · ES · contact PI
Project 7: RT-probed protein interaction study in solution$301,972
P50 · FY2021 · AI · contact PI
Project 7: RT-probed protein interaction study in solution$232,230
P50 · FY2020 · AI · contact PI
Project 7: RT-probed protein interaction study in solution$232,230
P50 · FY2019 · AI · contact PI
Project 7: RT-probed protein interaction study in solution$226,139
P50 · FY2018 · GM · contact PI
Project 7: RT-probed protein interaction study in solution$230,097
P50 · FY2017 · GM · contact PI
Conformational Dynamics and inhibitor responses of HIV-1 RT RNase H in solution$294,040
R01 · FY2016 · GM · contact PI
Project 4$158,556
P50 · FY2016 · GM · contact PI
Conformational Dynamics and inhibitor responses of HIV-1 RT RNase H in solution$135,288
R01 · FY2016 · GM · contact PI
Conformational Dynamics and inhibitor responses of HIV-1 RT RNase H in solution$293,322
R01 · FY2015 · GM · contact PI
Project 4$158,556
P50 · FY2015 · GM · contact PI
Conformational Dynamics and inhibitor responses of HIV-1 RT RNase H in solution$64,015
R01 · FY2015 · GM · contact PI
Conformational Dynamics and inhibitor responses of HIV-1 RT RNase H in solution$292,600
R01 · FY2014 · GM · contact PI
Project 4$158,556
P50 · FY2014 · GM · contact PI
Conformational Dynamics and inhibitor responses of HIV-1 RT RNase H in solution$27,901
R01 · FY2014 · GM · contact PI
Conformational Dynamics and inhibitor responses of HIV-1 RT RNase H in solution$289,750
R01 · FY2013 · GM · contact PI
Project 4$175,730
P50 · FY2013 · GM · contact PI
Project 4$456,958
P50 · FY2012 · GM · contact PI
Acylhydrazone inhibitors of HIV-1 ribonuclease H$374,273
R01 · FY2010 · AI
Acylhydrazone inhibitors of HIV-1 ribonuclease H$374,273
R01 · FY2009 · AI